{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:25:53Z","timestamp":1792185953635,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.prp.2022.153758","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:16:33Z","timestamp":1641554193000},"page":"153758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors"],"prefix":"10.1016","volume":"230","author":[{"given":"Chihiro","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Saito-Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Seyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.153758_bib1","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart: WHO Classification of Tumours","author":"Travis","year":"2015"},{"key":"10.1016\/j.prp.2022.153758_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.prp.2022.153758_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2022.153758_bib4","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2022.153758_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00428-014-1559-9","article-title":"In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor","volume":"464","author":"Gao","year":"2014","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2022.153758_bib6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.humpath.2015.02.019","article-title":"Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis","volume":"46","author":"Adachi","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2022.153758_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/01.pas.0000172192.25295.45","article-title":"Lymphangiogenesis-mediated sheddinq of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis","volume":"29","author":"Kumasaka","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153758_bib8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2353\/ajpath.2009.080830","article-title":"Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium","volume":"175","author":"Issaka","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2022.153758_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rmed.2012.10.006","article-title":"The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM)","volume":"107","author":"Xu","year":"2013","journal-title":"Respir. Med."},{"key":"10.1016\/j.prp.2022.153758_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI200421152","article-title":"Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis","volume":"114","author":"Watanabe","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2022.153758_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jb\/mvs128","article-title":"The vasohibin family: a novel family for angiogenesis regulation","volume":"153","author":"Sato","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.prp.2022.153758_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1349-7006.2008.01015.x","article-title":"Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis","volume":"100","author":"Tamaki","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2022.153758_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/pin.12931","article-title":"Vasohibin-1 and miR-720 expression in diffuse pulmonary capillary hemangiomatosis-like changes associated with pulmonary hypoplasia","volume":"70","author":"Saito","year":"2020","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2022.153758_bib14","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.2353\/ajpath.2010.090829","article-title":"Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis","volume":"176","author":"Heishi","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2022.153758_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/REP-11-0465","article-title":"Possible action of vasohibin-1 as an inhibitor in the regulation of vascularization of the bovine corpus luteum","volume":"143","author":"Shirasuna","year":"2012","journal-title":"Reproduction"},{"key":"10.1016\/j.prp.2022.153758_bib16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2004.12.073","article-title":"Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells","volume":"327","author":"Shimizu","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2022.153758_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1158\/1541-7786.MCR-12-0098-T","article-title":"Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis","volume":"10","author":"Takahashi","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.prp.2022.153758_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-014-0062-x","article-title":"MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"12","author":"Xue","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.prp.2022.153758_bib19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3892\/ol.2013.1119","article-title":"Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells","volume":"5","author":"Koyanagi","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2022.153758_bib20","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/cas.12297","article-title":"In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer","volume":"104","author":"Koyanagi","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2022.153758_bib21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/onc.2012.177","article-title":"Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma","volume":"32","author":"Xue","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.153758_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3727\/096504019X15509383469698","article-title":"VASH2 promotes cell proliferation and resistance to doxorubicin in non-small cell lung cancer via AKT signaling","volume":"28","author":"Tan","year":"2020","journal-title":"Oncol. Res."},{"key":"10.1016\/j.prp.2022.153758_bib23","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/cas.13411","article-title":"Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts","volume":"108","author":"Suzuki","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2022.153758_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cas.13157","article-title":"Vasohibin-2 is required for epithelial\u2013mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-\u03b2 signaling","volume":"108","author":"Norita","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2022.153758_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.humpath.2018.07.002","article-title":"Roles of human epidermal growth factor receptor family in pulmonary lymphangioleiomyomatosis","volume":"81","author":"Kobayashi","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2022.153758_bib26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.0000216747.66660.26","article-title":"Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin","volume":"26","author":"Shibuya","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prp.2022.153758_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0195779","article-title":"Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model","volume":"13","author":"Masuda","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2022.153758_bib28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","article-title":"Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)","volume":"28","author":"Hayashi","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2022.153758_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0797-9","article-title":"Immunohistological features related to functional impairment in lymphangioleiomyomatosis","volume":"19","author":"do Nascimento","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.prp.2022.153758_bib30","doi-asserted-by":"crossref","first-page":"F560","DOI":"10.1152\/ajprenal.00569.2013","article-title":"Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy","volume":"307","author":"Siroky","year":"2014","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.prp.2022.153758_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/01.pas.0000126859.70814.6d","article-title":"Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis","volume":"28","author":"Kumasaka","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153758_bib32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1369\/0022155413489311","article-title":"Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis cells","volume":"61","author":"Davis","year":"2013","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.prp.2022.153758_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1183\/09031936.05.00016905","article-title":"In vitro studies of lymphangioleiomyomatosis","volume":"26","author":"Black","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.prp.2022.153758_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/thx.2006.071811","article-title":"Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets","volume":"62","author":"Watz","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.prp.2022.153758_bib35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1158\/0008-5472.CAN-11-2167","article-title":"Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis","volume":"72","author":"Nagahashi","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.153758_bib36","first-page":"41","article-title":"Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelial-mesenchymal transition mediated by the FAK\/AKT\/MMPs axis","volume":"54","author":"Liu","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2022.153758_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.prp.2022.153758_bib38","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/bjc.2011.74","article-title":"Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors","volume":"104","author":"Bijnsdorp","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2022.153758_bib39","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1242\/jcs.067538","article-title":"Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion","volume":"123","author":"Suzuki","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.prp.2022.153758_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0109608","article-title":"TGF\u03b2-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen i (\u03b12) gene expression","volume":"9","author":"Das","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2022.153758_bib41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/cas.13149","article-title":"Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment","volume":"108","author":"Koyanagi","year":"2017","journal-title":"Cancer Sci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:49:47Z","timestamp":1759733387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":41,"alternative-id":["S0344033822000012"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153758","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153758"}}